Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis
Crossref DOI link: https://doi.org/10.1186/s12916-017-0954-x
Published Online: 2017-10-30
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Créquit, Perrine
Chaimani, Anna
Yavchitz, Amélie
Attiche, Nassima
Cadranel, Jacques
Trinquart, Ludovic
Ravaud, Philippe
Funding for this research was provided by:
Institut National Du Cancer (N° 2016-020/058/AB-KA)
LEGS POIX 2015 (Chancellerie des Universités de Paris)
